Results 231 to 240 of about 47,219,118 (367)

Loss of primary cilia promotes EphA2‐mediated endothelial‐to‐mesenchymal transition in the ovarian tumor microenvironment

Molecular Oncology, EarlyView.
Loss of primary cilia in endothelial cells promotes EndMT and vascular abnormalities in the ovarian tumor microenvironment through EphA2 activation. Using human samples, in vitro models, and endothelial‐specific Kif3a‐knockout mice, we show that primary cilia loss drives the acquisition of cancer‐associated fibroblast‐like phenotypes, thereby ...
Jin Gu Cho, Yubin Hah, Eunsik Yun, Hye In Ka, Aram Lee, Sora Han, Dawn Lee, Sung Wook Kim, Jong Hoon Park, Byung Su Kwon, Young Yang, Jongmin Kim   +11 more
wiley   +1 more source

Constitutional court: mirrored by Ukrainian politics [PDF]

, 2001
Research, Update
core  

Establishing Priorities for Clinical Education Research: Exploring the Views of UK Professional and Public Stakeholders. [PDF]

Clin Teach
Burford B, Yeates P, Bluemel AH, Park S, Sandars J, Henry C, Corness-Parr C, Conn R, Gale T, O'Brien T, Goddard-Fuller R, Vance G, Ellis J.   +12 more
europepmc   +1 more source

Research Spotlights [PDF]

SIAM Review, 2018
openaire   +16 more sources

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

Molecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski, Molly R. Danks, John P. Thomson, Morwenna Muir, Martin Lee, John C. Dawson, Ana T. Amaral, Juan Diaz‐Martin, David S. Moura, Javier Martin‐Broto, Ali Alsaadi, Donald M. Salter, Ailsa J. Oswald, Graeme Grimes, Larry Hayward, Ted R. Hupp, Karen Sisley, Paul H. Huang, Neil O. Carragher, Valerie G. Brunton   +19 more
wiley   +1 more source

Will the 31 March results be faked? [PDF]

, 2002
Research, Update
core  

Improving Clarity and Interpretability of Items in a Bilingual Index of Propensity to Integrate Research Evidence Into Clinical Decision-Making in Rehabilitation. [PDF]

J Eval Clin Pract
Roberge-Dao J, Mayo N, Rochette A, Shikako K, Thomas A.   +4 more
europepmc   +1 more source

Heredity in the light of recent research,

, 1910
L. Doncaster
openalex   +2 more sources

Population data on Finland 1900-1979

Finnish Yearbook of Population Research, 1980
Population Research Institute
doaj  

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

Molecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, Lejla Mahmutovic, Marcus Scharpf, Gunnar Blumenstock, Martin Schaller, Irina Bonzheim, Shayan Khozooei, Mahmoud Toulany   +9 more
wiley   +1 more source